Effektivnost' kombinirovannykh preparatov v terapii ostrykh vospalitel'nykh zabolevaniy LOR-organov
- Authors: Nosulya E.V1
-
Affiliations:
- Issue: No 15 (2014)
- Pages: 64-68
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287392
- ID: 287392
Cite item
Open Access
Access granted
Abstract
The high prevalence of acute respiratory infections (ARI) and the extremely low efficiency of prevention are largely attributable to the variety of etiologically significant pathogens. The main direction of causal treatment of ARVI includes the use of antiviral drugs. Along with this, combined drugs are widely used in the treatment of patients with SARS; the components of combined drugs affect the basic symptoms and pathogenetic mechanisms of respiratory viral infections. This group of drugs includes Caffetin Cold, which is composed of paracetamol, pseudoephedrine hydrochloride, dextromethorphan hydrobromide, and ascorbic acid. In general, the components of the drug Caffetin Cold, acting on the leading symptoms of ARVI, provide a vasoconstrictor, anti-inflammatory and antitussive effects. In this connection, application of Caffetin Cold at the early stages and/or in mild disease contributes to the regression of the symptoms of acute respiratory disease, and improvement of subjective feelings of patients.
Full Text
References
- Горелов А.В. Терапия острых инфекций и их осложнений. М., 2009. http://www.cmd-online.ru/price/5gorelov.pdf.
- Гендон Ю.З. Этиология острых респираторных заболеваний. Вакцинопрофилактика гриппа. 2001; 5(17).
- Лобзин Ю.В. Руководство по инфекционым болезням. СПб., 2000. 932 с.
- Anon J.B., Jacobs M.R., Poole M.D. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol. Head Neck Surg. 2004; 130(1 Suppl): 1-45.
- Каманин Е.И., Козлов Р.С., Веселов А.В. Острый бактериальный риносинусит. Клиническая микробиология и антимикробная химиотерапия. 2008; 10(1): 43-54.
- Хлыстов Ю.А., Мусорин Ю.Н. О распространенности синуситов. Совр. вопр. диагн. и леч. в оторинол. М., 1983. С. 149-56.
- Linder J.A., Stafford R.S. Antibiotic treatment of adults with sore throat by community primary care physicians. JAMA. 2001; 286: 1181-86.
- Centor R.M., Witherspoon J.M., Dalton H.P., et al. The diagnosis of strep throat in adults in the emergency room. Med. Decis. Making. 1981; 1: 239-46.
- Mclsaac W.J., White D., Tannenbaum D., Low D.E. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. Can. Med. Assoc. J. 1998; 158: 75-83.
- Пискунов С.З., Тарасов И.В., Медведкова И.Г. Лечебная тактика при риногенных орбитальных осложнениях. Российская ринология. 1995; 2: 48-9.
- Дерюгина О.В., Чумаков Ф.И. Орбитальные и внутричерепные осложнения воспалительных заболеваний носа и околоносовых пазух у взрослых и детей. М., 2001.
- Taverner D., Latte G.J. WITHDRAWN: Nasal decongestants for the common cold. Cochrane Database Syst. Rev. 2009; (2): CD001953. doi: 10.1002/14651858.CD001953.pub4.
- Kale P. Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers. Front Pharmacol. 2014; 9(5): 98.
Supplementary files
